A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure

被引:35
|
作者
Willems, Petra [1 ]
De Ruyck, Kim [1 ]
Van den Broecke, Rudy [2 ]
Makar, Amin [2 ,3 ]
Perletti, Gianpaolo [4 ]
Thierens, Hubert [1 ]
Vral, Anne [1 ]
机构
[1] Univ Ghent, Dept Basic Med Sci, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Gynaecol Oncol, B-9000 Ghent, Belgium
[3] Middelheim Hosp, Dept Gynaecol Oncol, B-2020 Antwerp, Belgium
[4] Univ Insubria, Dept Struct & Funct Biol, I-21052 Busto Arsizio, Italy
关键词
Double strand break (DSB) repair; Non-homologous end-joining (NHEJ); Ku70/XRCC6; Breast cancer; Hormone exposure; Single nucleotide polymorphism (SNP); END-JOINING GENES; CHROMOSOMAL RADIOSENSITIVITY; DNA END; REPAIR; BRCA1; PREDISPOSITION; SUSCEPTIBILITY; LYMPHOCYTES; MECHANISMS; DISEASE;
D O I
10.1007/s00432-009-0556-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Polymorphisms in double strand break repair genes could be involved in genetic breast cancer predisposition as enhanced chromosomal radiosensitivity is a hallmark for breast cancer. Previously, the c.-1310 C > G SNP, located in the Ku70 promoter, showed a significant odds ratio (OR) of 1.85 (P = 0.048) in sporadic, but not familial breast cancer patients, indicating that other factors besides genetic aptitude influence this association. As breast epithelium is exposed to endogenous oxidative stress through oestrogen exposure, the influence of hormone exposure was further examined. A significant OR (1.69, P = 0.017) was found for an enlarged patient population through PCR-RFLP assays in a case-control study in a Belgian population. After dividing the patient population according to oestrogen exposure, high and significant ORs were seen for patients with a longer oestrogen exposure (late age at menopause: OR = 1.96, P = 0.029). These results show that the variant allele of c.-1310 C > G, located in the Ku70 promoter, is a risk allele for breast cancer. Furthermore, the association of the c.-1310 C > G SNP with breast cancer risk was stronger in women with a long oestrogen exposure.
引用
收藏
页码:1159 / 1168
页数:10
相关论文
共 50 条
  • [21] Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk
    Langsenlehner, U
    Krippl, P
    Renner, W
    Yazdani-Biuki, B
    Eder, T
    Köppel, H
    Wascher, TC
    Paulweber, B
    Samonigg, H
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (02) : 113 - 115
  • [22] Association Between the Ku70-1310C/G Promoter Polymorphism and Cancer Risk: a Meta-analysis
    Xu, Lu
    Ju, Xiao-Bing
    Li, Pu
    Wang, Jue
    Shi, Zhu-Mei
    Zheng, Ming-Jie
    Xue, Dan-Dan
    Xu, Yan-jie
    Yin, Yong-mei
    Wang, Shui
    You, Yong-Ping
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (02) : 683 - 687
  • [23] A functional −77T>C polymorphism in XRCC1 is associated with risk of breast cancer
    Li Liu
    Peng Yuan
    Li Liu
    Chen Wu
    Xiaomin Zhang
    Huan Guo
    Rong Zhong
    Yihua Xu
    Jing Wu
    Shengyu Duan
    Rui Rui
    Tangchun Wu
    Shaofa Nie
    Xiaoping Miao
    Dongxin Lin
    [J]. Breast Cancer Research and Treatment, 2011, 125 : 479 - 487
  • [24] No association of the 5′ promoter region polymorphism of CYP17 with breast cancer risk in Japan
    Hamajima, N
    Iwata, H
    Obata, Y
    Matsuo, K
    Mizutani, M
    Iwase, T
    Miura, S
    Okuma, K
    Ohashi, K
    Tajima, K
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (09): : 880 - 885
  • [25] A functional-77T>C polymorphism in XRCC1 is associated with risk of breast cancer
    Liu, Li
    Yuan, Peng
    Liu, Li
    Wu, Chen
    Zhang, Xiaomin
    Guo, Huan
    Zhong, Rong
    Xu, Yihua
    Wu, Jing
    Duan, Shengyu
    Rui, Rui
    Wu, Tangchun
    Nie, Shaofa
    Miao, Xiaoping
    Lin, Dongxin
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 479 - 487
  • [26] A functional polymorphism in the promoter region of IL-33 is associated with the reduced risk of colorectal cancer
    Li, Zhao-Hui
    Han, Bao-Wei
    Zhang, Xie-Fu
    [J]. BIOMARKERS IN MEDICINE, 2019, 13 (07) : 567 - 576
  • [27] Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer
    Li, Qianjun
    Ma, Gang
    Sun, Suhua
    Xu, Ying
    Wang, Bingjian
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (05) : 478 - 482
  • [28] The-553 T/A polymorphism in the promoter region of the FGF2 gene is associated with increased breast cancer risk in Polish women
    Rykala, Jan
    Przybylowska, Karolina
    Majsterek, Ireneusz
    Pasz-Walczak, Grazyna
    Sygut, Andrzej
    Dziki, Adam
    Kuna, Piotr
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (03) : 619 - 627
  • [29] Functional mononucleotide repeat polymorphism in the promoter region of HGF is associated with risk and malignant aggressiveness of bladder cancer
    Chiba, Syuji
    Tsuchiya, Norihiko
    Horikawa, Yohei
    Narita, Shintaro
    Inoue, Takamitsu
    Akihama, Susumu
    Saito, Mitsuru
    Numakura, Kazuyuki
    Tsuruta, Hiroshi
    Huang, Mingguo
    Satoh, Shigeru
    Habuchi, Tomonori
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (03) : 678 - 684
  • [30] Identification of a DMBT1 Polymorphism Associated with Increased Breast Cancer Risk and Decreased Promoter Activity
    Tchatchou, Sandrine
    Riedel, Angela
    Lyer, Stefan
    Schmutzhard, Julia
    Strobel-Freidekind, Olga
    Gronert-Sum, Sabine
    Mietag, Carola
    D'Amato, Mauro
    Schlehe, Bettina
    Hemminki, Kari
    Sutter, Christian
    Ditsch, Nina
    Blackburn, Anneke
    Hill, Linda Zhai
    Jerry, D. Joseph
    Bugert, Peter
    Weber, Bernhard H. F.
    Niederacher, Dieter
    Arnold, Norbert
    Varon-Mateeva, Raymonda
    Wappenschmidt, Barbara
    Schmutzler, Rita K.
    Engel, Christoph
    Meindl, Alfons
    Bartram, Claus R.
    Mollenhauer, Jan
    Burwinkel, Barbara
    [J]. HUMAN MUTATION, 2010, 31 (01) : 60 - 66